Review

Published on 11 Oct 2023

Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance

in Molecular and Cellular Oncology

RF. Zaarour
M. Ribeiro
B. Azzarone
S. Kapoor
S. Chouaib

Frontiers in Oncology

doi 10.3389/fonc.2023.1222575

2,483 views
4 citations

Retraction

Published on 10 Oct 2023

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway

in Molecular and Cellular Oncology

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1298871

975 views

Case Report

Published on 09 Oct 2023

NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report

in Molecular and Cellular Oncology

Emanuela Palmerini
Giorgio Frega
Marco Gambarotti
Tommaso Frisoni
Marilena Cesari
Alberto Bazzocchi
Marco Miceli
Davide Maria Donati
Stefano Fanti
Cristina Nanni

Frontiers in Oncology

doi 10.3389/fonc.2023.1252359

1,795 views
2 citations

Editorial

Published on 09 Oct 2023

Editorial: Tumour microenvironment heterogeneity in hematological malignancies

in Molecular and Cellular Oncology

Silvia Deaglio
Ingo Ringshausen

Frontiers in Oncology

doi 10.3389/fonc.2023.1295996

1,085 views

Review

Published on 03 Oct 2023

MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis

in Molecular and Cellular Oncology

Aryan Rezaee
Sara Ahmadpour
Ameneh Jafari
Sarehnaz Aghili
Seyed Saeed Tamehri Zadeh
Ali Rajabi
Arash Raisi
Michael R. Hamblin
Maryam Mahjoubin-Tehran
Marzieh Derakhshan

Frontiers in Oncology

doi 10.3389/fonc.2023.1215194

2,316 views
3 citations

Review

Published on 02 Oct 2023

Pathogenesis and therapeutic implications of EBV-associated epithelial cancers

in Molecular and Cellular Oncology

Yi Hua Low
Celestine Jia Ling Loh
Daniel Yang Yao Peh
Axel Jun Ming Chu
Shuting Han
Han Chong Toh

Frontiers in Oncology

doi 10.3389/fonc.2023.1202117

3,268 views
2 citations

Original Research

Published on 29 Sep 2023

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer

in Molecular and Cellular Oncology

Zhongrui Wang
Xiqian Zhou
Xiaochong Deng
Danrong Ye
Diya Liu
Baian Zhou
Wenfang Zheng
Xuehui Wang
Yuying Wang
Oyungerel Borkhuu

Frontiers in Oncology

doi 10.3389/fonc.2023.1166666

1,852 views
2 citations

Original Research

Published on 28 Sep 2023

Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer

in Molecular and Cellular Oncology

Qian Yu
Susumu S. Kobayashi
Hiroshi Haeno

Frontiers in Oncology

doi 10.3389/fonc.2023.1137966

2,044 views

Editorial

Published on 28 Sep 2023

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

in Molecular and Cellular Oncology

Giulia Adriani
Paola Cappello
Sara Lovisa

Frontiers in Oncology

doi 10.3389/fonc.2023.1289756

1,313 views

Perspective

Published on 26 Sep 2023

Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?

in Molecular and Cellular Oncology

Pierluigi Scalia
Stephen J. Williams

Frontiers in Oncology

doi 10.3389/fonc.2023.1278402

880 views
1 citation

Review

Published on 26 Sep 2023

CD98 heavy chain as a prognostic biomarker and target for cancer treatment

in Molecular and Cellular Oncology

Pu Xia
Anna Dubrovska

Frontiers in Oncology

doi 10.3389/fonc.2023.1251100

7,215 views
8 citations

Review

Published on 26 Sep 2023

Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy

in Molecular and Cellular Oncology

Yoon-Jin Lee
Shinwon Chae
Dongsic Choi

Frontiers in Oncology

doi 10.3389/fonc.2023.1256585

3,444 views
2 citations

Review

Published on 22 Sep 2023

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

in Molecular and Cellular Oncology

Li Lin
Qing Wu
Feifei Lu
Jiaming Lei
Yanhong Zhou
Yifei Liu
Ni Zhu
You Yu
Zhifeng Ning
Tonghui She

Frontiers in Oncology

doi 10.3389/fonc.2023.1184079

10,040 views
17 citations

Review

Published on 21 Sep 2023

Evolution by innovation as a driving force to improve TCR-T therapies

in Molecular and Cellular Oncology

Dolores J. Schendel

Frontiers in Oncology

doi 10.3389/fonc.2023.1216829

5,614 views
1 citation

Review

Published on 20 Sep 2023

Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors

in Molecular and Cellular Oncology

Deena Elsori
Gowhar Rashid
Nihad Ashraf Khan
Punya Sachdeva
Riya Jindal
Falak Kayenat
Bhuvi Sachdeva
Mohammad Azhar Kamal
Asaad Ma Babker
Sherif Ashraf Fahmy

Frontiers in Oncology

doi 10.3389/fonc.2023.1265347

4,100 views
9 citations

Correction

Published on 20 Sep 2023

Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study

in Molecular and Cellular Oncology

Masahide Isowa
Reo Hamaguchi
Ryoko Narui
Hiromasa Morikawa
Hiromi Wada

Frontiers in Oncology

doi 10.3389/fonc.2023.1291026

659 views

Navigation group

Articles

Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway

NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report

Editorial: Tumour microenvironment heterogeneity in hematological malignancies

MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis

Pathogenesis and therapeutic implications of EBV-associated epithelial cancers

miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer

Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?

CD98 heavy chain as a prognostic biomarker and target for cancer treatment

Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

Evolution by innovation as a driving force to improve TCR-T therapies

Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors

Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study